For information on CME Accreditation, please go to General Information.
0645-0745 | Instructional Courses 1-4 | ||||||||||||||
IC-01: Male Reconstructive Urology for the General Urologist Chair: Joel Gelman, USA |
|||||||||||||||
0645-0650 |
Introduction Joel Gelman |
||||||||||||||
0650-0705 |
Urethral Stricture Initial Evaluation and Imaging Joel Gelman |
||||||||||||||
0705-0720 |
Algorithm for Managing Disorders of the Anterior and Posterior Urethra and Bladder Neck Daniela Andrich, UK |
||||||||||||||
0720-0735 |
Penile and Scrotal Disorders: Decision Making Keith Rourke, Canada |
||||||||||||||
0735-0745 | Discussion and Conclusion | ||||||||||||||
IC-02: Greenlight Laser Vaporization - Beyond the Learning Curve: Tackling the Tough Cases while Optimizing Durable Outcomes and Reducing Complications Chair: Kevin Zorn, Canada |
|||||||||||||||
0645-0705 |
Published Outcomes: Safety, Durability, Cost Effectiveness and Complications Alexander Bachmann, Switzerland |
||||||||||||||
0705-0725 |
Techniques for Large Prostates and Median Lobes Kevin Zorn |
||||||||||||||
0725-0745 |
Techniques to Avoid Complications (Dysuria, Capsulotomy, Sphincter Injury) / Management of Bleeding / Techniques for Small Prostates / Radiotherapy Henry Woo, Australia |
||||||||||||||
IC-03: Novel Molecular/Genetic Markers for Active Surveillance vs. Active Treatment Decisions for Localized Prostate Cancer Chair: Judd W. Moul, USA |
|||||||||||||||
0645-0650 |
Welcome and Introduction Judd W. Moul |
||||||||||||||
0650-0705 | Framing the Problem: Modern Active Surveillance: Who, How, Why and Challenges
Declan Murphy, Australia |
||||||||||||||
0705-0720 |
Myriad Prolaris vs Oncotype GPS Molecular Genetic Tissue Markers for Patients Considering Active Surveillance vs Active Treatment Judd W. Moul |
||||||||||||||
0720-0735 |
Use of Serum and Urine Markers (4K Score, PHI, PCA-3 etc.) in the Active Surveillance Algorithm Edmund Chiong, Singapore |
||||||||||||||
0735-0745 |
Question and Answers and Mock Tumor Board Case Examples All faculty |
||||||||||||||
IC-04: Functional and Anatomical Cause of MUS Complications, its Diagnosis, Imaging, and Management Chair: Ajit Vaze, India |
|||||||||||||||
0645-0650 |
Introduction Ajit Vaze |
||||||||||||||
0650-0655 |
Classification of the Complications John PFA Heesakkers, The Netherlands |
||||||||||||||
Anatomical Causes |
|||||||||||||||
0655-0700 |
Urethra Dirk de Ridder, Belgium |
||||||||||||||
0700-0705 |
Vaginal, Visceral John PFA Heesakkers |
||||||||||||||
0705-0710 |
Bladder Ajit Vaze |
||||||||||||||
0710-0715 |
Questions and Answers |
||||||||||||||
0715-0725 |
Functional Causes Dirk de Ridder |
||||||||||||||
How to Avoid Complications (Tricks of the Trade) |
|||||||||||||||
0725-0730 |
On the Table Ajit Vaze |
||||||||||||||
0730-0735 |
Immediately (1 Day—3 Weeks) John PFA Heesakkers |
||||||||||||||
0735-0740 |
Tricks for Delayed Complications Dirk de Ridder |
||||||||||||||
0740-0745 |
Questions and Answers |
||||||||||||||
0745-0800 | Break | ||||||||||||||
0800-1005 |
Plenary 1 |
||||||||||||||
Honorary Chairs: Inderbir Gill, United States, SIU Scientific Programme Chair Gerald Jordan, United States, SIU President |
|||||||||||||||
0800-0825 |
Welcome and SIU-Astellas European Foundation Lecture |
||||||||||||||
0825-0840 |
Confederación Americana de Urología Lecture Contemporary Management of Penile Cancer Fernando Secin, Argentina |
||||||||||||||
0840-0925 |
Shifting Sands: Testosterone Deficiency and Sexual Health Chair: Sae Woong Kim, South Korea |
||||||||||||||
0840-0853 |
Evolution of TRT Guidelines: From Erectile Dysfunction to LOH Du Geon Moon, South Korea |
||||||||||||||
0853-0906 |
Current Status of TRT in Sexual Health and Prostatic Disease Nathan Lawrentschuk, Australia |
||||||||||||||
0906-0919 |
Past, Present, Future of LOH in Asia-Pacific Men’s Health Hui Meng Tan, Malaysia |
||||||||||||||
0919-0925 |
Discussion |
||||||||||||||
0925-0950 |
Debate: Testosterone and Cardiac Death: Fact or Fiction? Moderator: Run Wang, USA Fact: Ajay Nehra, USA Fiction: Jack Barkin, Canada |
||||||||||||||
0950-1005 |
Urological Society of Australia and New Zealand Lecture Antibiotic Prophylaxis in Urological Surgery Shomik Sengupta, Australia |
||||||||||||||
1005-1025 | Break | ||||||||||||||
1025-1155 |
Parallel Plenary 1: Diet and Metabolic Aspects Chair: Neil Fleshner, Canada |
||||||||||||||
1025-1040 |
EULIS Lecture: Metabolic Syndrome and Stones Noor Buchholz, UAE and UK |
||||||||||||||
1040-1055 |
Stones and Diet Jose Reis-Santos, Portugal |
||||||||||||||
1055-1110 |
Metabolic Syndrome and Cancer Neil Fleshner |
||||||||||||||
1110-1125 |
Perioperative Nutrition Henry Woo, Australia |
||||||||||||||
1125-1155 |
Discussion, Question and Answer All |
||||||||||||||
1025-1155 |
Parallel Plenary 2: Master Class: Complex Penile and Urethral Reconstruction Surgery Chair: Ajay Nehra, USA |
||||||||||||||
Panelists: Sanjay Kulkarni, India Kurt McCammon, USA Jong Kwan Park, South Korea David Ralph, UK Giulio Garaffa, UK |
|||||||||||||||
Lecture Topics
|
|||||||||||||||
1025-1155 |
Parallel Plenary 3: ICUD: Image-Guided Therapy for Urology (Part 1: Prostate) Co-Chairs: Mihir Desai, USA / Rafael Sánchez Salas, France |
||||||||||||||
1025-1043 |
Goals of Initial Evaluation and Diagnosis in Prostate Cancer Jochen Walz, France |
||||||||||||||
1043-1101 |
Imaging in Localized Prostate Cancer Eric Barret, France |
||||||||||||||
1101-1119 |
Prostatic Biopsies: Available Techniques and Approaches Osamu Ukimura, USA |
||||||||||||||
1119-1137 |
Available Ablation Energies to Treat Prostate Cancer Jean de la Rosette, The Netherlands |
||||||||||||||
1137-1155 |
Surveillance After Focal Therapy Thomas Polascik, USA |
||||||||||||||
1025-1155 |
Surgical Tips 1: Nuances of Radical Prostatectomy Chair: Antonio Finelli, Canada |
||||||||||||||
1025-1035 |
Access, Developing Extraperitoneal Space, Endopelvic Fascia Gyung Tak Sung, South Korea |
||||||||||||||
1035-1050 | Bladder Neck, Pedicles Kevin Zorn, Canada |
||||||||||||||
1050-1105 | Nerve Sparing Rafael Sanchez-Salas, France |
||||||||||||||
1105-1120 | Apex and Anastomosis Anthony Costello, Australia |
||||||||||||||
1120-1135 | PLND +/- Nuances to Suspected T3 Cases Geoff Coughlin, Australia |
||||||||||||||
1135-1155 | Discussion, Question and Answer | ||||||||||||||
1025-1155 |
World Journal of Urology Workshop: Paper Writing and Reviewing Co-Chairs: Alexandre de la Taille, France / Thomas Herrmann, Germany |
||||||||||||||
1155-1310 |
Lunch Break in Exhibit Hall | ||||||||||||||
1310-1440 |
Parallel Plenary 4: Master Class: Management of the Azoospermic Male Chair: David de Kretser, Australia |
||||||||||||||
Panelists: Robert McLachlan, Australia Darren Katz, Australia |
|||||||||||||||
1310-1322 |
The Clinical Approach: History Taking and Examination Pertinent to the Problem |
||||||||||||||
1322-1334 |
What Are the Critical Points that Need to Be Ascertained on History? |
||||||||||||||
1334-1346 |
What Should You Look for on Examination? |
||||||||||||||
1346-1358 |
What Tests Need to Be Ordered? |
||||||||||||||
1358-1410 |
Interpretation of the History and Physical Examination |
||||||||||||||
1410-1422 |
Approaches to Treatment |
||||||||||||||
1422-1434 | Outcomes that You Might Expect | ||||||||||||||
1310-1440 |
Parallel Plenary 5: Global Perspectives: Common Pediatric Urology Problems Co-Chairs: Catherine DeVries, USA / Anette Jacobsen, Singapore |
||||||||||||||
1310-1325 | Undescended Testis
Anette Jacobsen |
||||||||||||||
1332-1347 |
Ureteropelvic Junction Obstruction Grahame Smith, Australia |
||||||||||||||
1354-1409 |
Penile Anomalies Catherine DeVries |
||||||||||||||
1416-1431 |
Dysfunctional Voiding and Enuresis Kara Saperston, USA |
||||||||||||||
1310-1440 |
Parallel Plenary 6: Shifting Sands: Salvage Surgery Co-Chairs: Sung Kyu Hong, South Korea / Maria Carmen Mir, Spain |
||||||||||||||
1310-1325 | Imaging Prior to Salvage Surgery: What Urologists Need To Know Nathan Lawrentschuk, Australia |
||||||||||||||
1325-1340 |
Post-Radiation and HIFU Salvage Radical Prostatectomy James Eastham, USA |
||||||||||||||
1340-1355 |
Salvage of Nodal Disease Post Initial Treatment for Prostate Cancer Maurizio Brausi, Italy |
||||||||||||||
1355-1410 |
Salvage Cystectomy Post Pelvic Radiation Seth Lerner, USA |
||||||||||||||
1410-1425 |
Renal Bed and Other Site RCC Recurrence Laura Izquierdo Reyes, Spain |
||||||||||||||
1425-1440 | Desperation Surgery in Testicular Cancer
Manish Patel, Australia |
||||||||||||||
1310-1630 |
Parallel Plenary 7 (Part 1): LUTS/BPH and Sex Co-Chairs: Mostafa Elhilali, Canada / Claus Roehrborn, USA |
||||||||||||||
1310-1325 |
Epidemiology and Pathophysiology of LUTS and Sex Claus Roehrborn |
||||||||||||||
Challenging Clinical Scenarios for Medical Management |
|||||||||||||||
1325-1333 |
Case 1 Mostafa Elhilali |
||||||||||||||
1333-1341 |
Case 2 Christopher Chapple, UK |
||||||||||||||
1341-1349 |
Case 3 Claus Roehrborn |
||||||||||||||
1349-1359 |
Break |
||||||||||||||
Unresolved Issues |
|||||||||||||||
1359-1407 |
Detrusor Underactivity Christopher Chapple |
||||||||||||||
1407-1415 |
Post-void Residual Urine Claus Roehrborn |
||||||||||||||
1415-1423 |
Intravesical Protrusion Christopher Cheng, Singapore |
||||||||||||||
1423-1431 |
Nocturia Claus Roehrborn |
||||||||||||||
1431-1440 |
Questions and Answers |
||||||||||||||
1440-1454 |
Debate: Is it Imperative to Do Invasive UDS before Surgical or MIS Options |
||||||||||||||
1440-1445 |
Pro Christopher Chapple |
||||||||||||||
1445-1450 |
Con Noor Buchholz, UK and UAE |
||||||||||||||
1450-1452 |
Rebuttal Christopher Chapple |
||||||||||||||
1452-1454 |
Rebuttal Noor Buchholz |
||||||||||||||
*See Parallel Plenary 7 (Part 2): LUTS/BPH and Sex in the section below.* |
|||||||||||||||
1310-1440 | Abstract Sessions | ||||||||||||||
Moderated ePosters MP-02: Bladder Cancer: Various Topics I |
|||||||||||||||
1310-1440 |
Urology Society of Australia and New Zealand Symposium (Part 1) Chair: Mark Frydenberg, Australia |
||||||||||||||
1310-1315 |
Introduction Mark Frydenberg |
||||||||||||||
1315-1325 |
The Development of HoLEP: Lessons Learned Peter Gilling, New Zealand |
||||||||||||||
1325-1335 |
The Management of High Risk Bladder Cancer in the Era of BCG Shortage Paul Anderson, Australia |
||||||||||||||
1335-1345 |
BRCA 1/2 Mutations, Evidence-Based Implications for Screening and Active Surveillance of Prostate Cancer Damien Bolton, Australia |
||||||||||||||
1345-1355 |
Results from the Victorian Trans-Perineal Prostate Biopsy Collaborative Group Jeremy Grummet, Australia |
||||||||||||||
1355-1405 |
Surgery for High-Risk Prostate Cancer Including Metastatic Disease Daniel Moon, Australia |
||||||||||||||
1405-1415 |
Targeting Tumour Metabolism in Prostate Cancer Neil Fleshner, Canada |
||||||||||||||
1415-1425 |
Management of Radiation Urethral Stricture Disease Justin Chee, Australia |
||||||||||||||
1425-1440 |
Discussion |
||||||||||||||
1440-1500 | Break | ||||||||||||||
1310-1630 |
Parallel Plenary 7 (Part 2): LUTS/BPH and Sex Co-Chairs: Mostafa Elhilali, Canada, Claus Roehrborn, USA |
||||||||||||||
1454-1502 |
What Constitutes a Surgical Gold Standard? Claus Roehrborn |
||||||||||||||
1502-1510 |
Challenges in Laser Prostatectomy: Addressing Prostate Size and the Learning Curve Mostafa Elhilali |
||||||||||||||
1510-1525 |
General Overview on the Use of Lasers Andreas Gross, Germany |
||||||||||||||
1525-1535 |
Break |
||||||||||||||
Emerging New Technology for MIS | |||||||||||||||
1535-1543 |
Urolift and REZUM Claus Roehrborn |
||||||||||||||
1543-1551 |
Aquablation, Histotripsy Peter Gilling, New Zealand |
||||||||||||||
1551-1559 |
Injectable (Sophiris PRX302) Mostafa Elhilali |
||||||||||||||
1559-1614 |
Debate: HoLEP versus Laparoscopic/Robotic Prostatectomy HoLEP: Peter Gilling Robotic: Mihir Desai, USA |
||||||||||||||
1614-1630 |
Last Resort Treatments |
||||||||||||||
1614-1622 |
Prostate Arterial Embolization TBC |
||||||||||||||
1622-1630 |
Intraurethral Stents Noor Buchholz |
||||||||||||||
1500-1630 |
Parallel Plenary 8: Shifting Sands: Infertility and Men’s Health Chair: Rupin Shah, India |
||||||||||||||
1500-1515 | Hypogonadotropic Hypogonadism and Men's Health Yasser Elkhiat, Egypt |
||||||||||||||
1515-1530 | Medical Conditions Associated with Oligozoospermia
Koji Shiraishi, Japan |
||||||||||||||
1530-1545 | Risk of Testicular Malignancy in Men with Testicular Failure
Mohit Khera, USA |
||||||||||||||
1545-1600 | Medical Consequences of Severe Hypogonadism Associated with Testicular Failure
Alayman Hussein, Egypt |
||||||||||||||
1600-1615 | Male Reproductive Surgery
Giulio Garaffa, UK |
||||||||||||||
1615-1630 | Discussion | ||||||||||||||
1500-1630 |
Parallel Plenary 9: Shifting Sands: Testicular Cancer Chair: Guy Toner, Australia |
||||||||||||||
1500-1520 |
Chemotherapy for CS IIA (and Low Volume IIB) Seminoma Manish Patel, Australia |
||||||||||||||
1520-1540 |
Optimal Templates for RPLND: Are Modified Templates Always Oncologically Safe? Michael Jewett, Canada |
||||||||||||||
1540-1600 |
Late Events in Testis Cancer Patients following Chemotherapy and Their Impact on Clinical Decision Making Guy Toner |
||||||||||||||
1600-1620 |
Chemotherapy, Surveillance or RPLND for CS I-B NSGCT Urs Studer, Switzerland |
||||||||||||||
1620-1630 |
Discussion |
||||||||||||||
1500-1630 |
Surgical Tips 2: Transplant Surgery Chair: Howard Lau, Australia |
||||||||||||||
1500-1512 | Kidneys with a Small Renal Mass: A Source for Live Renal Donation? Ming-Kwong Yiu, China |
||||||||||||||
1515-1527 | Optimal Management of Small Renal Mass in Renal Transplant
Marc-Olivier Timsit, France |
||||||||||||||
1530-1542 | Transplantation into a Diverted Urinary Tract: Timing, Type and Outcome
Ho Yee Tiong, Singapore |
||||||||||||||
1545-1557 | Laparoscopic and Robotic Renal Transplant: A Natural Progression?
Pranjal Modi, India |
||||||||||||||
1600-1612 | Renal Transplant in the Obese
Bulang He, Australia |
||||||||||||||
1615-1627 | Evolution of Laparoscopic Donor Nephrectomy: How to Minimize Post-operative Bleeding
Howard Lau |
||||||||||||||
1500-1630 | Abstract Sessions | ||||||||||||||
Moderated ePosters MP-05: Bladder Cancer: Various Topics II MP-06: Prostate Cancer: Biopsy & Active Surveillance |
|||||||||||||||
1500-1630 |
Urology Society of Australia and New Zealand Symposium (Part 2) Chair: Mark Frydenberg, Australia |
||||||||||||||
1500-1510 |
Current Concepts in Penile Rehabilitation Post Radical Prostatectomy Eric Chung, Australia |
||||||||||||||
1510-1520 |
Misclassification in Active Surveillance: Is this Improved with Pre-Biopsy MRI Mark Frydenberg |
||||||||||||||
1520-1530 |
The Role of PET PSMA in the Staging and Re-Staging of Prostate Cancer Declan Murphy, Australia |
||||||||||||||
1530-1540 |
Percutaneous Biopsies of Renal Tumours—Why, When, Who? Alessandro Volpe, Italy |
||||||||||||||
1540-1550 |
Management of Caval Thrombi in Renal Cell Carcinoma Andrew Williams, New Zealand |
||||||||||||||
1550-1600 |
Testis Sparing Surgery for Testis Cancer Nathan Lawrentschuk, Australia |
||||||||||||||
1600-1610 |
Smart Phone Apps, Electronic Patient Tools in Urology James Duthie, New Zealand |
||||||||||||||
1610-1625 |
Discussion |
||||||||||||||
1625-1630 |
Conclusion Mark Frydenberg |
||||||||||||||
1630-1730 | Australian Wine Tasting in Exhibit Hall | ||||||||||||||
1900-2200 | SIU Night at South Wharf Promenade |